Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4074-4081
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4074
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4074
Figure 1 Quality of life of patients in the control and research groups.
A-F: Quality of life of patients measured using the physical function (A), role function (B), emotional function (C), social function (D), cognitive function (E), and overall health scores (F). aP < 0.05 vs before treatment. bP < 0.01 vs before treatment.
Figure 2 Survival as measured using the 1-year overall survival and 1-year recurrence and metastasis rates.
A: 1-year overall survival; B: 1-year recurrence and metastasis rates.
Figure 3 Comparison of levels of serum inflammatory factors after treatment between the control and research groups.
A: Interleukin (IL)-6; B: IL-10; C: Tumor necrosis factor alpha. aP < 0.05 vs before treatment. bP < 0.01 vs before treatment; cP < 0.05 vs control group. IL: Interleukin; TNF-α: Tumor necrosis factor alpha.
- Citation: Wang YK, Zhu RW, Gao ZP, Tao Y. Quality of life and survival analyses of breast cancer cases treated with integrated traditional Chinese and Western medicine. World J Clin Cases 2024; 12(20): 4074-4081
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4074.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4074